The Nasdaq Composite (^IXIC) had the worst month of the year in September but there are signs that point to a potentially rally. Thanks to the August PCE report, some stocks have begun to claw back their losses. Alissa Coram, Investor’s Business Daily Executive Editor, joins Yahoo Finance's Jared Blikre to share their insights on the market and discuss some stand out stocks including Meta (META) and Baker Hughes Company (BKR), as well as Emerging markets ETF (EEM) and the performance of the U.S Dollar (DX-Y.NYB) Coram points out that when the Nasdaq broke its August lows, it shook out the "weak holders" and set the stage for a rally attempt. However, it's important to look for a "confirmation of a change in trends." Coram says she is looking specifically for a "follow through" day to confirm the move. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.
The Nasdaq Composite (^IXIC) had the worst month of the year in September but there are signs that point to a potentially rally. Thanks to the August PCE report, some stocks have begun to claw back their losses. Alissa Coram, Investor’s Business Daily Executive Editor, joins Yahoo Finance's Jared Blikre to share their insights on the market and discuss some stand out stocks including Meta (META) and Baker Hughes Company (BKR), as well as Emerging markets ETF (EEM) and the performance of the U.S Dollar (DX-Y.NYB)
Coram points out that when the Nasdaq broke its August lows, it shook out the "weak holders" and set the stage for a rally attempt. However, it's important to look for a "confirmation of a change in trends." Coram says she is looking specifically for a "follow through" day to confirm the move.
For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.
AP Finance
The Food and Drug Administration on Friday laid out a proposal to begin regulating laboratory medical tests, a multibillion-dollar industry that the agency says poses a growing risk to patients because of potentially inaccurate results. The proposed rule would end decades of regulatory ambiguity and formally bring thousands of tests performed in large laboratories under FDA oversight. FDA Commissioner Robert Califf said the change will help ensure tests used to diagnose cancer, heart disease and thousands of other conditions are safe, accurate and reliable.
Reuters
WASHINGTON (Reuters) -The U.S. Securities and Exchange Commission said on Thursday that advertising company Clear Channel Outdoor Holdings agreed to pay more than $26 million to resolve charges it bribed Chinese government officials to obtain outdoor ad contracts in violation of U.S. law. The SEC complaint alleged the company violated the U.S. Foreign Corrupt Practices Act through the actions of its agent, Clear Media Limited, which at the time was a Clear Channel majority-owned subsidiary in China. The SEC said from at least 2012 through 2017, Clear Media bribed Chinese government officials to obtain contracts required to sell advertising services to public and private sector clients for display on public bus shelters and other outdoor displays.
The Wall Street Journal
Jared Gross’s large corporate clients have been asking for a different kind of help over the past year. It is a change from the approach that Gross, JPMorgan head of institutional portfolio strategy, has taken for more than a decade: shifting workers’ retirement savings out of traditional stocks and bonds and into private equity and other complex strategies that can lock up money for a decade. Locking up funds for a long period is unpopular now because for the first time in years, easy-to-trade corporate bonds and bank loans offer appealing returns, thanks to rising interest rates.
Reuters
U.S. consumer spending increased in August, but underlying inflation moderated, with the year-on-year rise in prices excluding food and energy slowing to below 4.0%. With gasoline price surging, inflation as measured by the personal consumption expenditures (PCE) price index rose 0.4% in August after climbing 0.2% in July. In the 12 months through August, the PCE price index advanced 3.5% after rising 3.4% in July.
TipRanks
Along with the markets’ recent pullback, so has Cathie Wood’s flagship Ark Innovation ETF (ARKK) handed back some of the year’s prior gains. Nevertheless, it has still outpaced the broader markets this year. And despite growing bearish macro concerns, looking at how Wood expects the landscape to shape up, the ARK Invest CEO is optimistic her innovation-first approach will continue to deliver. “I do think that what’s happening this year is that the market is starting to look over the Fed’s moves…
Read more --->